Copyright
©The Author(s) 2020.
World J Cardiol. Jan 26, 2020; 12(1): 7-25
Published online Jan 26, 2020. doi: 10.4330/wjc.v12.i1.7
Published online Jan 26, 2020. doi: 10.4330/wjc.v12.i1.7
Table 2 Clinical characteristics of patients with heart failure with preserved ejection fraction and heart failure and reduced ejection fraction
| HFpEF | HFrEF | |
| Sex | Women (62%) | Men (60%) |
| Age (yr) | 74 | 70 |
| Obesity | 41.4% | 35.5% |
| Diabetes mellitus | 45% | 40% |
| Hypertension | 77% | 69% |
| Chronic kidney disease | 56% | 45% |
| Coronary artery disease | 50%` | 59% |
| Prior myocardial infarction | 24% | 36% |
| LV remodeling | Concentric | Eccentric |
| LV ejection fraction | ≥ 50% | < 40% |
| Atrial fibrillation in hospitalized patients | 65% | 53% |
| Ventricular dysrhythmias | 3% | 11% |
| Hospitalizations for heart failure | Increasing | Decreasing |
| Therapies that decrease mortality | None at present time | Beta-Blockers, ACE inhibitors, biventricular pacemakers, coronary revascularization |
- Citation: Henning RJ. Diagnosis and treatment of heart failure with preserved left ventricular ejection fraction. World J Cardiol 2020; 12(1): 7-25
- URL: https://www.wjgnet.com/1949-8462/full/v12/i1/7.htm
- DOI: https://dx.doi.org/10.4330/wjc.v12.i1.7